Welcome to The Monday Catch-Up. Menopause care is finally having a moment, and this week brings three stories worth your attention.
Could menopause care finally be getting the attention it deserves?
Cinven, a private equity firm, has agreed to buy Theramex, a company focused on women's health, in a deal reported at 2.6 billion euros. It is a big bet on menopause care, and a sign that this field is finally getting the investment it deserves. More investment should mean more research and more treatment options. That is something to watch, and to hope for.
Could hypermobility be causing your gut symptoms?
If you are hypermobile, your gut symptoms may be connected. Bloating, reflux, and constipation often travel with hypermobility. Food cannot fix hypermobility itself, but a dietitian can help you work on the gut side of it, so the symptoms get easier to live with.
Is hormone therapy safer for your heart than we thought?
A new abstract presented at the American Heart Association followed 52,330 women ages 45 to 59 for about 12 years. It found that contemporary hormone therapy was not linked to a higher risk of heart attack, stroke, blood clots, or death. That is reassuring news. One note: this is a conference abstract, not yet peer-reviewed research, so we will keep watching as the full study comes out.